SARS-CoV-2 Nucleocapsid Protein Antibody

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein (NP) Antibody is a chimaeric recombinant Monoclonal Antibody against SARS-CoV-2/COVID-19 NP, containing Mouse variable region and Human IgG1 constant region.

The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.

Target	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein
Clonality	Monoclonal
Clone	W246
Reactivity	Virus
Origin	Human
Expression	Recombinant
Tested Applications	ELISA
Host	Human, Mouse
Recommended dilutions	ELISA: 1/5000 - 1/10000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	Recombinant SARS-CoV-2 Nucleocapsid Protein
Isotype	IgG1
Form	Liquid
Storage	Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Buffer	PBS, pH 7.4.
Concentration	1 mg/ml
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.
Directions for use	Centrifuge before opening to ensure complete recovery of vial contents.

Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue